首页> 外文期刊>Journal of applied clinical medical physics / >Validation of fluence‐based 3D IMRT dose reconstruction on a heterogeneous anthropomorphic phantom using Monte Carlo simulation
【24h】

Validation of fluence‐based 3D IMRT dose reconstruction on a heterogeneous anthropomorphic phantom using Monte Carlo simulation

机译:使用蒙特卡洛模拟验证异质拟人模型上基于注量的3D IMRT剂量重建

获取原文
           

摘要

In this study, we evaluated the performance of a three-dimensional (3D) dose verification system, COMPASS version 3, which has a dedicated beam models and dose calculation engine. It was possible to reconstruct the 3D dose distributions in patient anatomy based on the measured fluence using the MatriXX 2D array. The COMPASS system was compared with Monte Carlo simulation (MC), glass rod dosimeter (GRD), and 3DVH, using an anthropomorphic phantom for intensity-modulated radiation therapy (IMRT) dose verification in clinical neck cases. The GRD measurements agreed with the MC within 5% at most measurement points. In addition, most points for COMPASS and 3DVH also agreed with the MC within 5%. The COMPASS system showed better results than 3DVH for dose profiles due to individual adjustments, such as beam modeling for each linac. Regarding the dose-volume histograms, there were no large differences between MC, analytical anisotropic algorithm (AAA) in Eclipse treatment planning system (TPS), 3DVH, and the COMPASS system. However, AAA underestimated the dose to the clinical target volume and Rt-Parotid slightly. This is because AAA has some problems with dose calculation accuracy. Our results indicated that the COMPASS system offers highly accurate 3D dose calculation for clinical IMRT quality assurance. Also, the COMPASS system will be useful as a commissioning tool in routine clinical practice for TPS.PACS number: 87.55.Qr, 87.56.Fc, 87.61.Bj
机译:在这项研究中,我们评估了三维(3D)剂量验证系统COMPASS版本3的性能,该系统具有专用的射线模型和剂量计算引擎。使用MatriXX 2D阵列,可以基于测量的注量来重建患者解剖结构中的3D剂量分布。在临床颈部病例中,使用拟人体模进行强度调制放射治疗(IMRT)剂量验证,将COMPASS系统与Monte Carlo模拟(MC),玻璃棒剂量计(GRD)和3DVH进行了比较。在大多数测量点,GRD测量与MC一致,误差在5%以内。此外,COMPASS和3DVH的大多数分数也与MC达成了5%的一致。由于进行了单独的调整,例如每个直线加速器的射束建模,COMPASS系统的剂量曲线显示出比3DVH更好的结果。关于剂量-体积直方图,MC,Eclipse处理计划系统(TPS),3DVH和COMPASS系统中的分析各向异性算法(AAA)之间没有较大差异。但是,AAA偏低了临床剂量和Rt-Parotid剂量。这是因为AAA在剂量计算准确性方面存在一些问题。我们的结果表明,COMPASS系统可为临床IMRT质量保证提供高度精确的3D剂量计算。同样,COMPASS系统将用作TPS常规临床实践中的调试工具.PACS编号:87.55.Qr,87.56.Fc,87.61.Bj

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号